[
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q4 2024 Commentary",
    "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
    "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461500,
      "headline": "Invesco Health Care Fund Q4 2024 Commentary",
      "id": 133273550,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
      "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Global Focus Fund Q4 2024 Commentary",
    "summary": "Class A shares at net asset value underperformed the MSCI All-Country World Growth Index but outperformed the Morningstar Global Growth Stock Funds Category average during Q4.",
    "url": "https://finnhub.io/api/news?id=55ffb63cfa856c1809c6a6e04bb0a1c7fc87468228a8b2c017088e66cc52cd0b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742452800,
      "headline": "Invesco Global Focus Fund Q4 2024 Commentary",
      "id": 133269217,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Class A shares at net asset value underperformed the MSCI All-Country World Growth Index but outperformed the Morningstar Global Growth Stock Funds Category average during Q4.",
      "url": "https://finnhub.io/api/news?id=55ffb63cfa856c1809c6a6e04bb0a1c7fc87468228a8b2c017088e66cc52cd0b"
    }
  }
]